PALACE_CHEMICALS_LIMITED - Accounts

PALACE CHEMICALS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2020
Company Registration No. 01377241 (England and Wales)
PALACE CHEMICALS LIMITED
COMPANY INFORMATION
Directors
Mr C Clapham
Mr C J Sweeney
Mr W Clapham
Mr J Percival
Mr S Clough
Mr S Ball
Mr D Stevenson
(Appointed 16 January 2020)
Secretary
Mr C J Sweeney
Company number
01377241
Registered office
Unit 49
Compass Industrial Park West
Speke
Liverpool
L24 1YA
Auditor
DSG
Castle Chambers
43 Castle Street
Liverpool
L2 9TL
Business address
Unit 49
Compass Industrial Park West
Speke
Liverpool
L24 1YA
PALACE CHEMICALS LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Directors' responsibilities statement
5
Independent auditor's report
6 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 23
PALACE CHEMICALS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 AUGUST 2020
- 1 -

The directors present the strategic report for the year ended 31 August 2020.

Fair review of the business

As shown in the company’s statement of comprehensive income, revenue for the year has increased by 10% and profit before tax has increased as a direct result. In the challenging market conditions that existed in the year, in addition to continued pressure on employment costs, the directors consider this to be a very strong performance.

 

The company continues to maintain strong controls over fixed costs and other overheads whilst also investing in manufacturing capability, quality, marketing and research and development to enable it to achieve its profitability targets.

Principal risks and uncertainties

There are a number of risks and uncertainties that can impact on the performance of Palace Chemicals Limited, some of which are beyond the control the company.

 

The directors consider two of the most significant risks faced by the company are the knock on effect of the UK’s withdrawal from the European Union and the economic disruption caused by the current global COVID-19 pandemic. These risks are managed by the Board as a whole and are the subject of regular board meetings.

 

The directors have considered the potential operational challenges posed by COVID-19 including, but not restricted to, an assessment of the robustness of their supply chain and broader logistic arrangements as well as the impact this might have on going concern. See the going concern accounting policy for further information, however the directors do not foresee any operational pressures to be caused by the COVID-19 situation or any material impact on the company.

 

The company monitors market trends and risks on an ongoing basis and takes corrective action as and when required.

 

Competitive pressure in all the markets it operates in are an ongoing risk to the company. To manage this risk the company maintains strong relationships with its customers with high levels of customer service and product

quality, range and value.

 

Fluctuations in the price and supply of key raw materials, including purchases from overseas, may also affect the profitability of the business. Purchasing policies and practices mitigate, where practicable, these risks. Inventory levels have increased significantly at the year end to mitigate the risks associated with Brexit. Post year end the company has continued to hold sufficient stock to provide stability through disruption caused by both Brexit and the COVID-19 pandemic.

 

Liquidity, foreign currency and credit risks are set out in the directors’ report.

Key performance indicators

Key performance indicators continue to be used throughout the business, and the financial indicators such as turnover, gross profit margin, profit before tax, trade debtors and stock levels are set out in the body of the accounts.

 

The cash balance at the year end was positive and the company maintains strong cash control which has enabled it to meet its obligations to suppliers and other creditors as they fall due.

 

The directors also consider other non-financial indicators to monitor the performance of the business. These include:

The company’s ability to react to market conditions with a flexible approach to their manufacturing and distribution capabilities.

PALACE CHEMICALS LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 2 -

Research and development. The company continues with a robust policy to develop new products to enhance its position in the marketplace.

Employees - The company continues to invest in its strategies for the training, development and retention of employees. Average headcount for 2020 was 81 (2019: 79).

On behalf of the board

Mr C Clapham
Director
26 May 2021
PALACE CHEMICALS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 AUGUST 2020
- 3 -

The directors present their annual report and financial statements for the year ended 31 August 2020.

Principal activities

The principal activities of the company in the year under review were the manufacture and sale of ceramic tile adhesives and building chemical products supplied to the building and DIY industry.

Results and dividends

The results for the year are set out on page 8.

Ordinary dividends were paid to Micrown Limited amounting to £351,604. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr C Clapham
Mr C J Sweeney
Mr W Clapham
Mr J Percival
Mr S Clough
Mr S Ball
Mr D Stevenson
(Appointed 16 January 2020)
Qualifying third party indemnity provisions

The company has made qualifying third party indemnity provisions for the benefit of its directors during the year. These provisions remain in force at the reporting date.

Financial instruments
Liquidity risk

The company manages its cash and borrowing requirements in order to maximise interest income and minimise interest expense, whilst ensuring the company has sufficient liquid resources to meet the operating needs of the business.

Foreign currency risk

The company’s principal foreign currency exposures arise from trading with overseas companies. Company policy permits but does not demand that these exposures may be hedged in order to fix the cost in sterling.

Credit risk

Investments of cash surpluses are made through banks and companies which must fulfil credit rating criteria approved by the Board.

 

All customers who wish to trade on credit terms are subject to credit verification procedures. Trade debtors are monitored on an ongoing basis and provision is made for doubtful debts where necessary.

Future developments

The company plans to continue to grow the business and its reputation throughout the industry. The external commercial environment is expected to remain competitive but management remain confident that the company will maintain or increase its market share going forward.

 

PALACE CHEMICALS LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 4 -
Auditor

In accordance with the company's articles, a resolution proposing that DSG be reappointed as auditor of the company will be put at a General Meeting.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
Mr C Clapham
Director
26 May 2021
PALACE CHEMICALS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 AUGUST 2020
- 5 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

PALACE CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PALACE CHEMICALS LIMITED
- 6 -
Opinion

We have audited the financial statements of Palace Chemicals Limited (the 'company') for the year ended 31 August 2020 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 31 August 2020 and of its profit for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

  • the directors' use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or

  • the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

PALACE CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF PALACE CHEMICALS LIMITED
- 7 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of directors' remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members, as a body, for our audit work, for this report, or for the opinions we have formed.

Iain White BSc FCA (Senior Statutory Auditor)
For and on behalf of DSG
26 May 2021
Chartered Accountants
Statutory Auditor
Castle Chambers
43 Castle Street
Liverpool
L2 9TL
PALACE CHEMICALS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 AUGUST 2020
- 8 -
2020
2019
Notes
£
£
Turnover
3
22,520,333
20,469,149
Cost of sales
(14,174,524)
(13,224,250)
Gross profit
8,345,809
7,244,899
Distribution costs
(3,271,232)
(3,213,007)
Administrative expenses
(1,704,210)
(1,630,409)
Other operating income
131,476
-
0
Operating profit
4
3,501,843
2,401,483
Interest receivable and similar income
7
40,962
32,458
Interest payable and similar expenses
8
(448)
(163)
Profit before taxation
3,542,357
2,433,778
Tax on profit
9
(543,118)
(455,523)
Profit for the financial year
2,999,239
1,978,255
PALACE CHEMICALS LIMITED
BALANCE SHEET
AS AT 31 AUGUST 2020
31 August 2020
- 9 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
12
3,775,895
3,835,116
Current assets
Stocks
13
2,311,202
2,865,793
Debtors
14
6,725,107
5,729,752
Cash at bank and in hand
10,058,509
7,045,395
19,094,818
15,640,940
Creditors: amounts falling due within one year
15
(3,303,222)
(2,574,571)
Net current assets
15,791,596
13,066,369
Total assets less current liabilities
19,567,491
16,901,485
Provisions for liabilities
Deferred tax liability
16
213,110
194,739
(213,110)
(194,739)
Net assets
19,354,381
16,706,746
Capital and reserves
Called up share capital
18
20,000
20,000
Revaluation reserve
190,320
195,200
Profit and loss reserves
19,144,061
16,491,546
Total equity
19,354,381
16,706,746
The financial statements were approved by the board of directors and authorised for issue on 26 May 2021 and are signed on its behalf by:
Mr C Clapham
Director
Company Registration No. 01377241
PALACE CHEMICALS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2020
- 10 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 September 2018
20,000
200,080
15,364,678
15,584,758
Year ended 31 August 2019:
Profit and total comprehensive income for the year
-
-
1,978,255
1,978,255
Dividends
10
-
-
(856,267)
(856,267)
Transfers
-
(4,880)
4,880
-
Balance at 31 August 2019
20,000
195,200
16,491,546
16,706,746
Year ended 31 August 2020:
Profit and total comprehensive income for the year
-
-
2,999,239
2,999,239
Dividends
10
-
-
(351,604)
(351,604)
Transfers
-
(4,880)
4,880
-
Balance at 31 August 2020
20,000
190,320
19,144,061
19,354,381
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2020
- 11 -
1
Accounting policies
Company information

Palace Chemicals Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 49, Compass Industrial Park West, Speke, Liverpool, L24 1YA.

1.1
Accounting convention

The financial statements are prepared under the historical cost convention modified to include the revaluation of leasehold land and buildings at deemed cost.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

FRS 102 allows a qualifying entity a number of disclosure exemptions subject to certain conditions being satisfied. These are the notification to the company's shareholders of the intention to take advantage of the allowable exemptions and the company receiving no objections to this intention.

 

On the basis that the company has satisfied the above stated conditions it has taken advantage of the following exemptions:

 

(i)     exemption from preparing a statement of cash flows, on the basis that it is a qualifying entity    whose parent company prepared consolidated financial statements include a Statement of Cash    Flows;

 

(ii)     exemption from disclosing transactions and balances with companies that are wholly owned    subsidiaries within the same group.

 

1.2
Going concern

As part of assessing the potential impact of the ongoing COVID-19 virus situation the directors have prepared revised financial forecasts. These forecasts indicate that the company will continue to trade profitably, and generate cash, over the period considered by them in their assessment of the appropriateness of adopting the going concern basis in the preparation of these financial statements. The directors have also considered the impact of potential operational challenges posed by COVID-19, including but not restricted to, an assessment of the robustness of their supply chain and broader logistics arrangements. The directors have concluded that any operational pressures caused directly by the COVID-19 situation are unlikely to have a material impact on the company. On this basis the directors consider it appropriate to prepare these financial statements on a going concern basis.true

1.3
Turnover

Turnover represents amounts derived from ordinary activities, and stated after trade discounts, other sales taxes and net of VAT.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on despatch of the goods or upon collection), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
1
Accounting policies
(Continued)
- 12 -
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or deemed cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Long leasehold property
2% straight line
Plant and machinery
15% reducing balance, 2% 5% and 10% on cost
Office furniture & fittings
15% reducing balance and 10% on cost
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Properties whose fair value can be measured reliably are held under the revaluation model and are carried at a revalued amount, being their fair value at the date of valuation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. The fair value of the land and buildings is usually considered to be their market value.

 

Revaluation gains and losses are recognised in other comprehensive income and accumulated in equity, except to the extent that a revaluation gain reverses a revaluation loss previously recognised in profit or loss or a revaluation loss exceeds the accumulated revaluation gains recognised in equity; such gains and losses are recognised in profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
1
Accounting policies
(Continued)
- 13 -
1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
1
Accounting policies
(Continued)
- 14 -
Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
1
Accounting policies
(Continued)
- 15 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.13
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 16 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Impairment of debtors

Management reviews the carrying amount of trade receivables on a regular basis to identify items where recoverability may be in doubt. The timing and quantum of any impairment of receivables is a matter of management judgement. Details of such impairments are detailed in Note 15 to these financial statements.

Impairment of stock

The company maintains material levels of stock in order to satisfy current and future sales orders. Management reviews stock on a regular basis to ensure that there is no material accumulation of items that are obsolete or otherwise impaired. The timing and quantum of any stock impairment is a matter of management judgement which is also partially dependent on projected sales activity which is an area of uncertainty. Details of such impairments are detailed in Note 14 to these financial statements.

Depreciation of fixed assets

Management review the useful economic life and residual value of their fixed assets. The assets are then depreciated over their useful economic life less any residual value. Both the useful economic life and residual value of an asset are a matter of management judgement. Details of the depreciation rates can be found in Note 1.4 to these financial statements.

3
Turnover and other revenue

An analysis of the company's turnover is as follows:

2020
2019
£
£
Turnover analysed by class of business
Sale of goods
22,520,333
20,469,149
2020
2019
£
£
Other significant revenue
Interest income
40,962
32,458
Grants received
131,476
-
0
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
3
Turnover and other revenue
(Continued)
- 17 -
2020
2019
£
£
Turnover analysed by geographical market
United Kingdom
17,538,970
15,762,471
Europe
3,704,322
3,632,808
Middle East
1,270,977
1,064,597
Africa
3,901
8,158
South America
2,163
1,115
22,520,333
20,469,149
4
Operating profit
2020
2019
Operating profit for the year is stated after charging/(crediting):
£
£
Government grants
(131,476)
-
0
Fees payable to the company's auditor for the audit of the company's financial statements
17,821
17,235
Depreciation of owned tangible fixed assets
312,861
331,383
Profit on disposal of tangible fixed assets
(557)
-
0
Impairment of trade debtors recognised or reversed
23,292
15,950
Operating lease charges
64,917
65,518
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Management
6
6
Production
50
44
Selling and distribution
12
15
Administration
13
14
81
79
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
5
Employees
(Continued)
- 18 -

Their aggregate remuneration comprised:

2020
2019
£
£
Wages and salaries
2,611,968
2,526,223
Social security costs
261,451
245,227
Pension costs
30,838
24,297
2,904,257
2,784,865
6
Directors' remuneration
2020
2019
£
£
Remuneration for qualifying services
863,703
853,401
Company pension contributions to defined contribution schemes
4,433
3,557
868,136
856,958

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 4 (2019 - 4).

Remuneration disclosed above include the following amounts paid to the highest paid director:
Remuneration for qualifying services
262,827
275,489

The directors are considered to be the key management personnel.

7
Interest receivable and similar income
2020
2019
£
£
Interest income
Interest on bank deposits
40,962
32,458

Investment income includes the following:

Interest on financial assets not measured at fair value through profit or loss
40,962
32,458
8
Interest payable and similar expenses
2020
2019
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank overdrafts and loans
448
163
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 19 -
9
Taxation
2020
2019
£
£
Current tax
UK corporation tax on profits for the current period
617,632
472,281
Adjustments in respect of prior periods
(92,885)
(761)
Total current tax
524,747
471,520
Deferred tax
Origination and reversal of timing differences
18,371
(15,997)
Total tax charge
543,118
455,523

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2020
2019
£
£
Profit before taxation
3,542,357
2,433,778
Expected tax charge based on the standard rate of corporation tax in the UK of 19.00% (2019: 19.00%)
673,048
462,418
Tax effect of expenses that are not deductible in determining taxable profit
2,634
3,871
Adjustments in respect of prior years
(92,885)
(761)
Effect of change in corporation tax rate
22,910
-
0
Permanent capital allowances in excess of depreciation
14,114
27,605
Other permanent differences
(76,703)
(37,610)
Taxation charge for the year
543,118
455,523
10
Dividends
2020
2019
£
£
Interim paid
351,604
856,267
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 20 -
11
Intangible fixed assets
Goodwill
£
Cost
At 1 September 2019 and 31 August 2020
100,000
Amortisation and impairment
At 1 September 2019 and 31 August 2020
100,000
Carrying amount
At 31 August 2020
-
0
At 31 August 2019
-
0
12
Tangible fixed assets
Long leasehold property
Plant and machinery
Office furniture & fittings
Motor vehicles
Total
£
£
£
£
£
Cost or valuation
At 1 September 2019
2,489,235
5,622,141
554,552
405,068
9,070,996
Additions
-
0
165,242
16,598
90,544
272,384
Disposals
-
0
-
0
-
0
(102,879)
(102,879)
At 31 August 2020
2,489,235
5,787,383
571,150
392,733
9,240,501
Depreciation and impairment
At 1 September 2019
436,381
4,195,003
383,586
220,910
5,235,880
Depreciation charged in the year
49,785
172,516
26,622
63,938
312,861
Eliminated in respect of disposals
-
0
-
0
-
0
(84,135)
(84,135)
At 31 August 2020
486,166
4,367,519
410,208
200,713
5,464,606
Carrying amount
At 31 August 2020
2,003,069
1,419,864
160,942
192,020
3,775,895
At 31 August 2019
2,052,854
1,427,138
170,966
184,158
3,835,116

Land and buildings are carried at valuation. If land and buildings were measured using the cost model, the carrying amounts would have been approximately £1,812,748 (2019 - £1,857,653), being cost £2,389,235 (2019 - £2,389,235) and depreciation £576,487 (2019 - £531,582).

PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 21 -
13
Stocks
2020
2019
£
£
Raw materials and consumables
1,959,170
2,295,169
Finished goods and goods for resale
352,032
570,624
2,311,202
2,865,793

An impairment loss of £100,200 (2019: £117,771) has been recognised against stock.

 

14
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
5,264,087
4,226,347
Amounts owed by group undertakings
1,209,622
1,209,622
Prepayments and accrued income
251,398
293,783
6,725,107
5,729,752

Trade debtors disclosed above are measured at amortised cost.

 

An impairment loss of £42,827 (2019: £15,998) has been recognised against trade debtors.

 

Amounts owed by group undertakings are interest free, hence have no fixed date of repayment and are repayable upon demand.

15
Creditors: amounts falling due within one year
2020
2019
£
£
Trade creditors
1,521,092
1,005,511
Corporation tax
279,028
274,281
Other taxation and social security
500,533
433,845
Accruals and deferred income
1,002,569
860,934
3,303,222
2,574,571
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 22 -
16
Deferred taxation

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2020
2019
Balances:
£
£
ACAs
213,110
194,739
2020
Movements in the year:
£
Liability at 1 September 2019
194,739
Charge to profit or loss
18,371
Liability at 31 August 2020
213,110
17
Retirement benefit schemes

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

The charge to profit or loss in respect of defined contribution schemes was £30,838 (2019: £24,297).

18
Share capital
2020
2019
£
£
Ordinary share capital
Issued and fully paid
14,650 "A" Ordinary shares of £1 each
14,650
14,650
5,350 "B" Ordinary shares of £1 each
5,350
5,350
20,000
20,000

The separate classes of shares shall be considered as being identical in all respects except for dividend levels which are set for each class.

19
Financial commitments, guarantees and contingent liabilities

There is a bank cross guarantee with Micrown Limited, the parent company. The potential exposure to the company at 31 August 2020 is £nil (2019: £nil).

PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 23 -
20
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2020
2019
£
£
Within one year
66,058
60,998
Between two and five years
137,045
173,075
203,103
234,073
21
Ultimate controlling party

The parent company is Micrown Limited, a company incorporated in Great Britain and registered in England and Wales. The registered office is Unit 49 Compass Industrial Park West, Speke, Liverpool, L24 1YA. Micrown Limited prepares consolidated financial statements which includes Palace Chemicals Limited.

 

The smallest and largest group into which the results of this entity are consolidated is that headed by Micrown Limited.

2020-08-312019-09-01falseCCH SoftwareCCH Accounts Production 2021.100Mr C ClaphamMr W ClaphamMr J PercivalMr S CloughMr S BallMr D StevensonMr D StevensonMr C J Sweeney013772412019-09-012020-08-3101377241bus:Director12019-09-012020-08-3101377241bus:CompanySecretaryDirector12019-09-012020-08-3101377241bus:Director22019-09-012020-08-3101377241bus:Director32019-09-012020-08-3101377241bus:Director42019-09-012020-08-3101377241bus:Director52019-09-012020-08-3101377241bus:Director62019-09-012020-08-3101377241bus:CompanySecretary12019-09-012020-08-3101377241bus:Director72019-09-012020-08-3101377241bus:RegisteredOffice2019-09-012020-08-31013772412020-08-31013772412018-09-012019-08-31013772412019-08-3101377241core:LandBuildingscore:LeasedAssetsHeldAsLessee2020-08-3101377241core:PlantMachinery2020-08-3101377241core:FurnitureFittings2020-08-3101377241core:MotorVehicles2020-08-3101377241core:LandBuildingscore:LeasedAssetsHeldAsLessee2019-08-3101377241core:PlantMachinery2019-08-3101377241core:FurnitureFittings2019-08-3101377241core:MotorVehicles2019-08-3101377241core:CurrentFinancialInstrumentscore:WithinOneYear2020-08-3101377241core:CurrentFinancialInstrumentscore:WithinOneYear2019-08-3101377241core:CurrentFinancialInstruments2020-08-3101377241core:CurrentFinancialInstruments2019-08-3101377241core:ShareCapital2020-08-3101377241core:ShareCapital2019-08-3101377241core:RevaluationReserve2020-08-3101377241core:RevaluationReserve2019-08-3101377241core:RetainedEarningsAccumulatedLosses2020-08-3101377241core:RetainedEarningsAccumulatedLosses2019-08-3101377241core:ShareCapitalcore:RestatedAmount2018-08-3101377241core:RevaluationReservecore:RestatedAmount2018-08-3101377241core:RetainedEarningsAccumulatedLossescore:RestatedAmount2018-08-3101377241core:RestatedAmount2018-08-3101377241core:ShareCapitalOrdinaryShares2020-08-3101377241core:ShareCapitalOrdinaryShares2019-08-3101377241core:RetainedEarningsAccumulatedLosses2018-09-012019-08-3101377241core:LandBuildingscore:LeasedAssetsHeldAsLessee2019-09-012020-08-3101377241core:PlantMachinery2019-09-012020-08-3101377241core:FurnitureFittings2019-09-012020-08-3101377241core:MotorVehicles2019-09-012020-08-3101377241bus:HighestPaidDirector2019-09-012020-08-3101377241core:UKTax2019-09-012020-08-3101377241core:UKTax2018-09-012019-08-310137724112019-09-012020-08-310137724112018-09-012019-08-3101377241core:Goodwill2019-08-3101377241core:Goodwill2020-08-3101377241core:Goodwill2019-08-3101377241core:LandBuildingscore:LeasedAssetsHeldAsLessee2019-08-3101377241core:PlantMachinery2019-08-3101377241core:FurnitureFittings2019-08-3101377241core:MotorVehicles2019-08-31013772412019-08-3101377241core:WithinOneYear2020-08-3101377241core:WithinOneYear2019-08-3101377241core:BetweenTwoFiveYears2020-08-3101377241core:BetweenTwoFiveYears2019-08-3101377241bus:PrivateLimitedCompanyLtd2019-09-012020-08-3101377241bus:FRS1022019-09-012020-08-3101377241bus:Audited2019-09-012020-08-3101377241bus:FullAccounts2019-09-012020-08-31xbrli:purexbrli:sharesiso4217:GBP